Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
Cong‐Fei Xu, Zi-Dong Lu, Ying‐Li Luo, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Base editing: advances and therapeutic opportunities
Elizabeth M. Porto, Alexis C. Komor, Ian M. Slaymaker, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 12, pp. 839-859
Open Access | Times Cited: 351
Design of therapeutic biomaterials to control inflammation
Zhaoxu Tu, Yiling Zhong, Hanze Hu, et al.
Nature Reviews Materials (2022) Vol. 7, Iss. 7, pp. 557-574
Open Access | Times Cited: 322
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Ai‐Ming Yu, Young Hee Choi, Mei‐Juan Tu
Pharmacological Reviews (2020) Vol. 72, Iss. 4, pp. 862-898
Open Access | Times Cited: 310
Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles
Ji Liu, Jin Chang, Ying Jiang, et al.
Advanced Materials (2019) Vol. 31, Iss. 33
Open Access | Times Cited: 305
Role of Pyroptosis in Cardiovascular Diseases and its Therapeutic Implications
Cheng Zeng, Renqing Wang, Hongmei Tan
International Journal of Biological Sciences (2019) Vol. 15, Iss. 7, pp. 1345-1357
Open Access | Times Cited: 247
Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes
Sujuan Ding, Sheng Xu, Yong Ma, et al.
Biomolecules (2019) Vol. 9, Iss. 12, pp. 850-850
Open Access | Times Cited: 191
Nanoenabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD-1 Therapy
Yuxue Zhang, Yangyang Zhao, Jizhou Shen, et al.
Nano Letters (2019) Vol. 19, Iss. 5, pp. 2774-2783
Closed Access | Times Cited: 187
Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy
Tianxia Lan, Li Chen, Xiawei Wei
Cells (2021) Vol. 10, Iss. 1, pp. 100-100
Open Access | Times Cited: 172
Rational designs of in vivo CRISPR-Cas delivery systems
Cong‐Fei Xu, Guojun Chen, Ying‐Li Luo, et al.
Advanced Drug Delivery Reviews (2019) Vol. 168, pp. 3-29
Closed Access | Times Cited: 160
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Matthew Behr, Jing Zhou, Bing Xu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 8, pp. 2150-2171
Open Access | Times Cited: 155
Microneedle-assisted genome editing: A transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders
Tao Wan, Qi Pan, Ping Yuan
Science Advances (2021) Vol. 7, Iss. 11
Open Access | Times Cited: 154
Emerging mRNA technologies: delivery strategies and biomedical applications
Yufen Xiao, Zhongmin Tang, Xiangang Huang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 10, pp. 3828-3845
Closed Access | Times Cited: 150
Biomedical polymers: synthesis, properties, and applications
Wei‐Hai Chen, Qi‐Wen Chen, Qian Chen, et al.
Science China Chemistry (2022) Vol. 65, Iss. 6, pp. 1010-1075
Open Access | Times Cited: 132
Carrier strategies boost the application of CRISPR/Cas system in gene therapy
Zunkai Xu, Qingnan Wang, Haiping Zhong, et al.
Exploration (2022) Vol. 2, Iss. 2
Open Access | Times Cited: 80
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
Xiaoqin Zheng, Jia Wan, Gang Tan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 57
Engineering nanoparticle toolkits for mRNA delivery
Bing Sun, Weixi Wu, Eshan A. Narasipura, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 115042-115042
Open Access | Times Cited: 54
Biomaterials for in situ cell therapy
Chang Wang, Siyu Wang, Diana D. Kang, et al.
BMEMat (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 45
Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape
Xiang Li, Jing Qi, Juan Wang, et al.
Theranostics (2024) Vol. 14, Iss. 2, pp. 738-760
Open Access | Times Cited: 30
Engineering approaches for RNA-based and cell-based osteoarthritis therapies
Carlisle R. DeJulius, Bonnie L. Walton, Juan M. Colazo, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 81-100
Closed Access | Times Cited: 29
NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation
Tao Yu, Dan Hou, Jiaqi Zhao, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114070-114070
Open Access | Times Cited: 28
Nanoplatform‐Based In Vivo Gene Delivery Systems for Cancer Therapy
Rui Luo, Hao Le, Qinjie Wu, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 17
NLRP3 inflammasome in health and disease (Review)
Haoran Wang, Li Ma, Weiran Su, et al.
International Journal of Molecular Medicine (2025) Vol. 55, Iss. 3
Closed Access | Times Cited: 2
Engineering Nanoparticles to Reprogram the Tumor Immune Microenvironment for Improved Cancer Immunotherapy
Madiha Saeed, Jing Gao, Yang Shi, et al.
Theranostics (2019) Vol. 9, Iss. 26, pp. 7981-8000
Open Access | Times Cited: 134
Delivery of CRISPR/Cas9 for therapeutic genome editing
Xiaojie Xu, Tao Wan, Huhu Xin, et al.
The Journal of Gene Medicine (2019) Vol. 21, Iss. 7
Open Access | Times Cited: 123
Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer
Man Li, Hanbing Xie, Yingke Liu, et al.
Journal of Controlled Release (2019) Vol. 304, pp. 204-215
Closed Access | Times Cited: 111
Page 1 - Next Page

Scroll to top